Evelyn Tönnissen

A Novel Method to Compensate for Different Amplification Efficiencies between Patient DNA Samples in Quantitative Real-Time PCR

Jules P.P. Meijerink, Caroline M.P.W. Mandigers, Louis van de Locht et al. · Journal of Molecular Diagnostics · 2001 · 308 citations · Full text

Medicine, Molecular Biology, Molecular Genetics +12

Lack of correlation between numbers of circulating t(14;18)-positive cells and response to first-line treatment in follicular lymphoma

Caroline M.P.W. Mandigers, Jules P.P. Meijerink, E. J. B. M. Mensink et al. · Blood · 2001 · 64 citations · Full text

Medicine, Hematology, Oncology +12

<i>BCL-2/IgH</i> Polymerase Chain Reaction Status at the End of Induction Treatment Is Not Predictive for Progression-Free Survival in Relapsed/Resistant Follicular Lymphoma: Results of a Prospective Randomized EORTC 20981 Phase III Intergroup Study

Marinus H. J. van Oers, Evelyn Tönnissen, M. van Glabbeke et al. · Journal of Clinical Oncology · 2010 · 53 citations · Full text

Medicine, Hematology, Oncology +17

Expression of <i>C‐IAP1</i>, <i>C‐IAP2</i> and <i>SURVIVIN</i> discriminates different types of lymphoid malignancies

Aniek O. de Graaf, J. Han van Krieken, Evelyn Tönnissen et al. · British Journal of Haematology · 2005 · 43 citations · Full text

Life Sciences, Hematology, Oncology +17

Minimal residual disease quantification in patients with acute myeloid leukaemia and inv(16)/CBFB‐MYH11 gene fusion

Bert A. van der Reijden, Annet Simons, Erna B Luiten et al. · British Journal of Haematology · 2002 · 39 citations

Medicine, Hematology, Oncology +17